Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9140841rdf:typepubmed:Citationlld:pubmed
pubmed-article:9140841lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:9140841lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:9140841lifeskim:mentionsumls-concept:C1955862lld:lifeskim
pubmed-article:9140841lifeskim:mentionsumls-concept:C0920715lld:lifeskim
pubmed-article:9140841lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:9140841lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:9140841pubmed:issue2lld:pubmed
pubmed-article:9140841pubmed:dateCreated1997-7-8lld:pubmed
pubmed-article:9140841pubmed:abstractTextIncreased tolerance to ischemia exhibited in chronically hypoxia immature rabbit hearts is associated with increased activation of ATP-sensitive potassium (KATP) channels. We determined whether exposure to hypoxia from birth alters the electrophysiological characteristics of Purkinje fibers obtained from rabbits (n = 12/group) which were raised in a normoxic (F O2 = 0.21) or hypoxic (F1O2 = 0.12) environment from birth to 9 days of age and the involvement of the KATP channel. The endocardial surface was exposed and impaled with microelectrodes to record action potential characteristics from Purkinje fibers under control conditions and following exposure to glibenclamide (3 microM). Action potential durations (APD)90 in Purkinje fibers were significantly shorter in hypoxic hearts compared with normoxic controls (110 +/- 5 ms v 121 +/- 4 ms). Glibenclamide increased APD90 in hypoxic hearts (120 +/- 4 ms) to values similar to those observed in normoxic controls (121 +/- 4 ms). Glibenclamide had no effect on APD90 in normoxic hearts. Maximum diastolic potential was more negative in hypoxic hearts and this effect was attenuated by glibenclamide. We conclude that chronic myocardial hypoxia results in a shorter APD as compared with normoxic controls by enhanced activation of KATP channels.lld:pubmed
pubmed-article:9140841pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9140841pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9140841pubmed:languageenglld:pubmed
pubmed-article:9140841pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9140841pubmed:citationSubsetIMlld:pubmed
pubmed-article:9140841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9140841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9140841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9140841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9140841pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9140841pubmed:statusMEDLINElld:pubmed
pubmed-article:9140841pubmed:monthFeblld:pubmed
pubmed-article:9140841pubmed:issn0022-2828lld:pubmed
pubmed-article:9140841pubmed:authorpubmed-author:GrossG JGJlld:pubmed
pubmed-article:9140841pubmed:authorpubmed-author:BakerJ EJElld:pubmed
pubmed-article:9140841pubmed:authorpubmed-author:BosnjakZ JZJlld:pubmed
pubmed-article:9140841pubmed:authorpubmed-author:ContneyS JSJlld:pubmed
pubmed-article:9140841pubmed:issnTypePrintlld:pubmed
pubmed-article:9140841pubmed:volume29lld:pubmed
pubmed-article:9140841pubmed:ownerNLMlld:pubmed
pubmed-article:9140841pubmed:authorsCompleteYlld:pubmed
pubmed-article:9140841pubmed:pagination845-8lld:pubmed
pubmed-article:9140841pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:meshHeadingpubmed-meshheading:9140841-...lld:pubmed
pubmed-article:9140841pubmed:year1997lld:pubmed
pubmed-article:9140841pubmed:articleTitleKATP channel activation in a rabbit model of chronic myocardial hypoxia.lld:pubmed
pubmed-article:9140841pubmed:affiliationDepartment of Pharmacology, Medical College of Wisconsin, Milwaukee 53226, USA.lld:pubmed
pubmed-article:9140841pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9140841pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:9140841pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:9140841pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9140841lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9140841lld:pubmed